Results 31 to 40 of about 527,356 (286)

Development of cryptotanshinone-loaded pellets for angina chronotherapy: In vitro/in vivo prediction and evaluation

open access: yesAsian Journal of Pharmaceutical Sciences, 2018
The clinical manifestations of variant angina is unevenly distributed during the 24 h, thus the in vivo performance of drugs should be tailored according to the angina circadian rhythm.
Zhenghua Li   +3 more
doaj   +1 more source

ACUTE CORONARY SYNDROME DUE TO CORONARY VASOSPASM – CASE REPORT

open access: yesРациональная фармакотерапия в кардиологии, 2017
Spasm of the coronary arteries is a dynamic narrowing of one or more coronary arteries, leading to significant restriction of the lumen. The leading role in coronary  artery spasm diagnostic belongs to coronary  angiography and its accompanying ...
S. D. Klimovskiy   +5 more
doaj   +1 more source

Clinical Outcomes of Vasospastic Angina Patients Presenting With Acute Coronary Syndrome

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundCoronary vasospasm is an important pathogenesis of acute coronary syndrome (ACS). However, the clinical features and prognosis of vasospastic angina (VA) patients presenting with ACS (VAACS) are still unclear.
Sung Woo Cho   +13 more
doaj   +1 more source

Successful infusional 5-fluorouracil administration in a patient with vasospastic angina

open access: yesAmerican Heart Journal Plus, 2022
A 48-year-old female with metastatic colon adenocarcinoma and history of pre-existing coronary vasospasm with ventricular tachycardia (VT) successfully tolerated de novo 5-fluorouracil (5-FU) chemotherapy infusions with prophylactic administration and ...
Shannon Tai   +8 more
doaj   +1 more source

A case of variant angina treated with a pacemaker for cardiopulmonary arrest due to complete atrioventricular block and pulseless electrical activity

open access: yesJournal of Arrhythmia, 2013
A 55-year-old woman with variant angina was hospitalized for cardiopulmonary arrest because of pulseless electrical activity (PEA). Despite intensive postresuscitation drug therapy, another episode of angina occurred, with complete atrioventricular block
Kazuho Kamishima   +9 more
doaj   +1 more source

Relationship between NAFLD and coronary artery disease: A Mendelian randomization study

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims There is an ongoing debate on whether NAFLD is an active contributor or an innocent bystander in the pathogenesis of coronary artery disease (CAD). The aim of the present study was to assess the causal relationship between NAFLD and CAD.
Zhewen Ren   +4 more
wiley   +1 more source

Combination of Variant and Microvascular Angina [PDF]

open access: yesClinical Cardiology, 2009
AbstractPrinzmetal's variant angina (VA) and cardiac syndrome X (CSX) are two distinct, usually easily recognizable, forms of angina syndromes, caused by epicardial spasm, usually responsible for transient transmural myocardial ischemia at rest and by coronary microvascular dysfunction (CMVD), usually responsible for effort induced subendocardial ...
Fabio, Infusino   +5 more
openaire   +2 more sources

Evaluation of the Predictive Value of Left Anterior Fascicular Block on Determination of Left Main and/or Proximal Left Anterior Descending Coronary Artery Disease in Patients with Stable Angina: A Propensity Score Matching Analysis

open access: yesİstanbul Medical Journal, 2021
Introduction:Successful revascularization of lesions located in the left main and/or proximal left anterior descending (LM and/or pLAD) coronary artery improves survival than medical therapy only.
Ömer Faruk Çırakoğlu   +2 more
doaj   +1 more source

Medical Management of Angina Pectoris

open access: yes, 2021
Ischemic heart disease is nowadays the leading cause of death in the world and is most commonly presented as "Angina pectoris", characterised by chest pain and discomfort. Many strategies exist in the treatment of angina which include medical therapy and
Padganeh, Negin
core  

Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial [PDF]

open access: yes, 2008
Background: Patients with refractory angina have significant morbidity. This study aimed to compare two of the treatment options, Spinal Cord Stimulation (SCS) and Percutaneous Myocardial Laser Revascularisation (PMR) in terms of clinical outcomes and ...
Goldsmith KA   +40 more
core   +4 more sources

Home - About - Disclaimer - Privacy